Microsoft’s AI chief Mustafa Suleyman makes a definitive case against AI consciousness, arguing that machines only simulate experience. His stance has profound implications for AI rights and development priorities.
octonomy’s €18.5 million funding round signals a major shift in enterprise AI. The German startup’s agentic systems achieve 95% accuracy on complex technical workflows, potentially disrupting traditional service models across heavy industries.
Rare earth mining stocks are experiencing historic rallies, with some companies seeing 500% gains this year. The critical minerals race represents a fundamental shift in global power dynamics and energy security.
Germany’s Commerzbank is considering abandoning its landmark Frankfurt headquarters in a dramatic cost-cutting move. The potential exit from the Norman Foster-designed tower reflects broader industry pressures reshaping European banking.
BDO’s exploration of private capital to fund mergers reveals deeper industry tensions. The accounting giant faces a critical choice between rapid growth through external funding and preserving its traditional partnership independence.
The Simandou deposit in Guinea represents one of the largest untapped iron ore reserves globally. After decades of delays, China’s massive investment could reshape global steel markets, but the project faces unprecedented challenges.
Indonesia’s ambitious high-speed rail project, backed by Chinese loans, is facing a financial crisis with mounting losses and debt restructuring negotiations. The “Whoosh” bullet train between Jakarta and Bandung has become a cautionary tale for infrastructure megaprojects in emerging markets.
Sam Altman’s testy response to revenue questions reveals deeper tensions about OpenAI’s path to profitability. The CEO confirmed revenue exceeding $13 billion annually while dismissing concerns about the company’s massive compute spending.
The pharmaceutical industry’s race for obesity treatments has turned into a legal battle as Pfizer sues to block Novo Nordisk’s competing $9 billion bid for Metsera. This represents a major escalation in the fight for next-generation weight loss drugs.
Samsung’s Galaxy S26 Ultra launch faces a significant delay, pushing back to February 25, 2026. The postponement reflects deeper industry challenges and strategic realignments that could reshape the premium smartphone market.
